Clinical Trials Logo

AL-Hijama in Thalassmia Major clinical trials

View clinical trials related to AL-Hijama in Thalassmia Major.

Filter by:
  • None
  • Page 1

NCT ID: NCT02761395 Recruiting - Clinical trials for AL-Hijama in Thalassmia Major

Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major

Al-hijamah
Start date: November 2015
Phase: N/A
Study type: Interventional

1. Evaluate the therapeutic effects, health benefits, and immunological effect of Al-hijamah in children with beta thalassemia major. 2. Evaluate the extent of clinical improvement, reductions in serum iron and ferritin, antioxidant status, in those patients.